Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Implanet S.A. (IMPZY)

Compare
0.0800
0.0000
(0.00%)
At close: April 15 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Ludovic Lastennet CEO, Commercial Director & Director 315.76k -- --
Mr. David Dieumegard Vice President of Financial -- -- --
Ms. Yvanna Peigne Operations Manager -- -- --

Implanet S.A.

Technopole Bordeaux Montesquieu
AllEe FranCois Magendie
Martillac, 33650
France
33 5 57 99 55 55 https://www.implanet.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
40

Description

Implanet S.A., a medical technology company, manufactures and sells implants for orthopedic surgery. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. The company was founded in 2006 and is based in Martillac, France.

Corporate Governance

Implanet S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

February 16, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers